| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/01/2004 | WO2004029219A3 Cell-based rna interference and related methods and compositions |
| 07/01/2004 | WO2004020600A3 Modified aav |
| 07/01/2004 | WO2004019865A3 Amelioration of effects of cigarette smoke |
| 07/01/2004 | WO2004018512A3 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 07/01/2004 | WO2004011489A3 Tropism-modified adenoviral vectors, preferably for targeting b-lymphocytes or ovarian cells |
| 07/01/2004 | WO2004009022A3 Method for augmenting vision in persons suffering from photoreceptor cell degeneration |
| 07/01/2004 | WO2003104416A3 Spliceosome mediated rna trans-splicing in stem cells |
| 07/01/2004 | WO2003100435A3 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) |
| 07/01/2004 | WO2003092716A3 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders |
| 07/01/2004 | WO2003092582A3 Chimeric ebola virus envelopes and uses therefor |
| 07/01/2004 | WO2003051278A3 Nanoparticle delivery vehicle |
| 07/01/2004 | WO2003048202A3 Nf-kappab activating genes |
| 07/01/2004 | WO2003040366A3 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/01/2004 | WO2003030719A9 Methods and kits for use in selecting approaches to treating cancer |
| 07/01/2004 | WO2003029429A9 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 07/01/2004 | WO2002099083A3 Gfats as modifiers of the p53 pathway and methods of use |
| 07/01/2004 | WO2002062834A3 Mixture of peptides originating from a nef protein and applications thereof |
| 07/01/2004 | US20040128706 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 07/01/2004 | US20040127696 Growth differentiation factor-7 |
| 07/01/2004 | US20040127686 Signal transduction regulator binding protein for identifying modulators for prevention and treatment of cardiomyopic hypertrophy, heart failure and diabetes; drug screening |
| 07/01/2004 | US20040127684 Heat shock protein-based vaccines and immunotherapies |
| 07/01/2004 | US20040127451 strategy with which to derive treatments for hyperproliferative disorders, developmental disorders, inflammatory disorders, neural disorders and diseases arising from aberrant apoptosis |
| 07/01/2004 | US20040127449 endothelial nitric oxide synthase gene is transduced into the lungs of said patient in a viral vector |
| 07/01/2004 | US20040127448 introducing a DNA construct into a pancreas cell in vivo, which encodes a protein and a eukaryotic promoting sequence to be expressed and delivered into the blood stream of the mammal |
| 07/01/2004 | US20040127445 methods for screening for compounds capable of modulating the effect of B2M activity such as inhibitors, antibodies, variants or mimetics |
| 07/01/2004 | US20040127441 Compositions and Methods for Treatment of Prostate and Other Cancers |
| 07/01/2004 | US20040127439 Introduction of the wld gene for prevention of axonal degeneration in neurological diseases |
| 07/01/2004 | US20040127438 polypeptide (or its encoding nucleic acid molecule from Mycobacterium tuberculosis or related prokaryotes in the treatment of cancer, allergic disorders or conditions of immunoactivation, particularly asthma |
| 07/01/2004 | US20040127437 Combined therapeutical treatment of hyperproliferative diseases |
| 07/01/2004 | US20040127410 Circular permuteins of flt3 ligand |
| 07/01/2004 | US20040127401 CA125 gene and its use for diagnostic and therapeutic interventions |
| 07/01/2004 | US20040126885 Delivery vehicle for recombinant proteins |
| 07/01/2004 | US20040126884 Transfecting heterologous gene sequences into mucosal cells, over a period of months, using naked DNA adhered to microparticles comprising a synthetic, biocompatible, biodegradable matrix |
| 07/01/2004 | US20040126882 Transforming cells with plasmid containing catalytic nucleotide sequences and using catalytic entity to control transcriptional expression of heterologus genes |
| 07/01/2004 | US20040126871 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 07/01/2004 | US20040126863 Comprises amino acid sequences for use in identifying modulators for diagnosis and treatment of respiratory and diabetes-induced peripheral vascular diseases; mimetics |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | US20040126841 Novel G-protein coupled receptor, HLTEX11 |
| 07/01/2004 | US20040126801 Novel polynucleotides and encoded polypeptides |
| 07/01/2004 | US20040126791 Compositions and methods for treating trail-resistant cancer cells |
| 07/01/2004 | US20040126785 Metastatic colon cancer specific promoter and uses thereof |
| 07/01/2004 | US20040126391 Meningococcal antigens |
| 07/01/2004 | US20040126377 Genetic engineered polypeptides; screening, design, genetic mapping; antibodies; psychological disorders, antidepressants |
| 07/01/2004 | US20040126371 Hormone polypeptides; genetic engineering; leukemia therapy |
| 07/01/2004 | US20040126364 Antiinflammatory agents; genetic engineered interleukins; oral diseases |
| 07/01/2004 | US20040126362 Anticancer agents; leukemia ; therapy, prevent of metabolism diseases |
| 07/01/2004 | CA2840513A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 07/01/2004 | CA2807515A1 Alphavirus particles and methods for preparation |
| 07/01/2004 | CA2511665A1 Endothelial cell specifically binding peptides |
| 07/01/2004 | CA2509979A1 Alphavirus particles and methods for preparation |
| 07/01/2004 | CA2509973A1 Multi-antigenic alphavirus replicon particles and methods |
| 07/01/2004 | CA2509831A1 Method of diagnosis of obesity |
| 07/01/2004 | CA2509642A1 Culture medium composition, culture method, and myoblasts obtained, and their uses |
| 07/01/2004 | CA2509520A1 Identification of oligonucleotides for the capture, detection and quantitation of west nile virus |
| 06/30/2004 | EP1433855A2 Plasmids suitable for il-2 expression |
| 06/30/2004 | EP1433851A2 Improved expression of HIV polypeptides and production of virus-like particles |
| 06/30/2004 | EP1433849A1 NOVEL POLYPEPTIDE, DNA THEREOF AND USE OF THE SAME |
| 06/30/2004 | EP1433847A1 Method of interfering with gene expression in mammalian post-implantation embryos |
| 06/30/2004 | EP1433845A1 Clostridium tetani collagenase and uses thereof |
| 06/30/2004 | EP1432824A2 Compositions and methods relating to prostate specific genes and proteins |
| 06/30/2004 | EP1432803A2 Fragments of the human zn-alpha2-glycoprotein and their use in methods of treatment of obesity |
| 06/30/2004 | EP1432791A1 Alphavirus replicon vector systems |
| 06/30/2004 | EP1432738A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 06/30/2004 | EP1432736A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 06/30/2004 | EP1432732A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/30/2004 | EP1432729A2 Peyers's patch and/or m-cell targeting ligands |
| 06/30/2004 | EP1432726A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2004 | EP1432724A1 Rna interference mediated inhibition of map kinase genes |
| 06/30/2004 | EP1432723A2 Modulation of the expression of genes dependent on stat-1 |
| 06/30/2004 | EP1432722A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/30/2004 | EP1432452A2 Inhibition of stat-1 |
| 06/30/2004 | EP1432448A2 Novel molecules of the hkid-1-related protein family and uses thereof |
| 06/30/2004 | EP1432441A2 Use of hmgb1 for the activation of dendritic cells |
| 06/30/2004 | EP1432440A2 Adjuvants for nucleic acid vaccines |
| 06/30/2004 | EP1432438A2 Use of rank antagonists to treat cancer |
| 06/30/2004 | EP1432433A2 Antagonists |
| 06/30/2004 | EP1432432A2 A cancer treatment system |
| 06/30/2004 | EP1112366B1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 06/30/2004 | EP1032418B1 Compact epstein-barr virus replicons |
| 06/30/2004 | EP1007637B1 Methods for increasing the efficiency of recombinant aav product |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509333A Novel neurotrophic factors |
| 06/30/2004 | CN1509328A Use of opg ligand to modulate immune response |
| 06/30/2004 | CN1509292A Combination apparoach to treatment of cancer using C-MYC antisense oligomer |
| 06/30/2004 | CN1508265A Interleukin-2 and tes method of its gene in drug-stopping application |
| 06/30/2004 | CN1508248A Tumour related gene and use thereof |
| 06/30/2004 | CN1508143A Contruction of cDNA library of cell differential expression using LCM technology and rat testicular specific gene RSD-6 cloning and biolobical function |
| 06/30/2004 | CN1507875A 肿瘤基因开关药物 Tumor gene switch drugs |
| 06/30/2004 | CN1507874A Tumour gene switch medicine |
| 06/30/2004 | CN1507873A 肿瘤基因开关药物 Tumor gene switch drugs |
| 06/30/2004 | CN1155706C Method for treating amyotrophic lateral sclerosis |
| 06/29/2004 | US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756201 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 06/29/2004 | US6756042 Salmonella vaccine; immunogenicity; reduced possibility of strain revertion to reactive form; safe; limited side effects |
| 06/29/2004 | US6756038 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
| 06/29/2004 | CA2276570C Method of pcr testing of pooled blood samples |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/24/2004 | WO2004053169A1 Modulation of interleukin 18 expression |
| 06/24/2004 | WO2004053162A1 Method of distinguishing drug-resistance of hepatitis b virus |